Maxigen BiotechTPE:1783 87 Days Inventory is 138.39 as of Dec. 2025, which is 5% above its 10-year median of 131.45. GuruFocus rates TPE:1783 with a GF Score™ of 87/100 and a GF Value™ of NT$61.21 (Significantly Undervalued). Among 784 Medical Devices & Instruments companies, Maxigen Biotech ranks better than 73.47% on this metric.
The historical rank and industry rank for Maxigen Biotech's Days Inventory or its related term are showing as below:
TPE:1783'
s Days Inventory Range Over the Past 10 Years
Min: 118.86 Med: 131.45 Max: 167.39
Current: 118.86
During the past 13 years, Maxigen Biotech's highest Days Inventory was 167.39. The lowest was 118.86. And the median was 131.45.
TPE:1783's Days Inventory is ranked better than 73.47% of 784
companies
in the Medical Devices & Instruments industry
Industry Median: 179.115
vs TPE:1783: 118.86
Maxigen Biotech's Days Inventory
increased
from Dec. 2024 (126.21) to Dec. 2025 (138.39).
It might indicate that Maxigen Biotech's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Maxigen Biotech's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.66.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Maxigen Biotech's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.40.
Maxigen Biotech (TPE:1783) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Maxigen Biotech's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Maxigen Biotech's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Maxigen Biotech Days Inventory Related Terms
Maxigen Biotech Days Inventory Historical Data
* Premium members only.
The historical data trend for Maxigen Biotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:1783 vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Maxigen Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maxigen Biotech Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Maxigen Biotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Maxigen Biotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maxigen Biotech (TPE:1783) has a Days Inventory of 138.39 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Maxigen Biotech and its competitors. This is near median its historical median of 131.45. Over the past decade, Maxigen Biotech's Days Inventory has ranged from 118.86 to 167.39. According to the industry distribution chart, Maxigen Biotech ranks #208 out of 784 companies in the Medical Devices & Instruments industry, placing it in the top 26.5%.
Is Maxigen Biotech's Days Inventory too high?
Maxigen Biotech's current Days Inventory of 138.39 is near median its 10-year median of 131.45. Over the past 10 years, this metric has ranged from a low of 118.86 to a high of 167.39. The Medical Devices & Instruments industry median Days Inventory is 179.12. Maxigen Biotech's value of 138.39 is 22.7% below this industry median. Based on the distribution chart, Maxigen Biotech ranks #208 out of 784 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Maxigen Biotech has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maxigen Biotech's Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Maxigen Biotech ranks #208 out of 784 companies for Days Inventory. This puts Maxigen Biotech in the upper half of its industry. The industry median Days Inventory is 179.12. Maxigen Biotech's value of 138.39 is 22.7% below this benchmark. Historically, Maxigen Biotech's own Days Inventory has ranged from 118.86 to 167.39 over the past decade. While the company's 10-year median is 131.45 vs. the industry median of 179.12, Maxigen Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.12, based on 784 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maxigen Biotech's current Days Inventory of 138.39 is 22.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Maxigen Biotech and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maxigen Biotech's current Days Inventory is 138.39, which is near median its own 10-year median of 131.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maxigen Biotech stock overvalued right now?
Based on GuruFocus' analysis, Maxigen Biotech (TPE:1783) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$61.21, compared to a current price of NT$40.35 — trading 34.1% below its estimated fair value. The current Days Inventory is 138.39, which is near median its 10-year median of 131.45 and 22.7% below the Medical Devices & Instruments industry median of 179.12. Maxigen Biotech's overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Maxigen Biotech (TPE:1783), the current Days Inventory is 138.39 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maxigen Biotech (TPE:1783) Overvalued in 2026?
Based on GuruFocus' analysis, Maxigen Biotech stock appears to be undervalued.
The current stock price of NT$40.35 is trading 34.1% below its estimated GF Value™ of NT$61.21.
GuruFocus considers Maxigen Biotech to be Significantly Undervalued.
Key valuation signals for TPE:1783:
Days Inventory: 138.39 (near median its 10-year median of 131.45)
GF Value™: NT$61.21 vs. price of NT$40.35 (34.1% below fair value)
Industry Position: 22.7% below the Medical Devices & Instruments median (#208 of 784)
No single metric tells the full story. See the TPE:1783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maxigen Biotech Inc is engaged in collagen purification, research and development, production and sales of implantable medical device, and production, manufacturing, wholesale and retail of cosmetics. The group had two reportable segments: the biomedical products segment and consumer products segment. Biomedical products segment is engaged in the manufacturing and sales of collagen and bone materials. The consumer products segment is involved in the manufacturing and sales of beauty care products. Geographically, it operates in Taiwan, America, Europe, Asia, and other countries, with the majority of the revenue deriving from Taiwan.
87GF Score
Get the complete analysis for TPE:1783
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1783 has been successfully added to your 
